Latest news
Loading news…
AcertaPharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Francisco, California, United States Founded 2013 51-100 employees For Profit
Acerta Pharma provides drug discovery and development services for oncology and autoimmune diseases.
AcertaPharma was acquired by AstraZeneca in 2015 for $4B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
72
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 9
- Active products
- 17
- IT spend
- $845.11K
Company Info
- Founded
- 2013
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 5
- News articles
- 3
- HQ
- San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Diversity spotlight
- Women Founded
- Exit date
- Dec 17, 2015
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -0.4
72
professional contacts at AcertaPharma
Contact execs at AcertaPharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to AcertaPharma
Loading news…
FAQs about AcertaPharma
People who checked this page also checked these
Browse the full Acquirezy directory.